Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Genitourinary 3Sarcoma 1Other solid neoplasm 1Gastrointestinal 1CNS 1

Conditions

Retinoblastoma 10Wilms Tumor 5Neuroblastoma 5Medulloblastoma 5Hepatoblastoma 5Sarcoma 4Carcinoma, Renal Cell 4Rhabdomyosarcoma 3Rhabdoid Tumor 3Osteosarcoma 3Central Nervous System Neoplasms 3Astrocytoma 3Testicular Neoplasms 2Sarcoma, Ewing 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Liver Neoplasms 2Kidney Neoplasms 2Brain Neoplasms 2Uveal Melanoma 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocytopenia 1Teratoma 1Sarcoma, Clear Cell 1Retinal Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1

Interventions

Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Melphalan 1Granulocyte Colony-Stimulating Factor 1Busulfan 1Bone Marrow Transplantation 1Arsenic Trioxide 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Germ Cell Cancer × Granulocyte Colony-Stimulating Factor × Other solid neoplasm × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡